Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease
International Journal of Molecular Sciences · 26.12.2023 · 25 (1) · 360
DOI: 10.3390/ijms25010360 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.12.2023. Verfasst von Kamil Saramowicz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Chemistry and Biochemistry, Medical University of Lodz, 92-215 Lodz, Poland. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Parkinson Disease. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 344 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lodz, National Science Center.
Abstract (Originalsprache)
Parkinson’s disease (PD) is a complex neurodegenerative disease characterized by the progressive loss of dopaminergic neurons in the substantia nigra and the widespread accumulation of alpha-synuclein (αSyn) protein aggregates. αSyn aggregation disrupts critical cellular processes, including synaptic function, mitochondrial integrity, and proteostasis, which culminate in neuronal cell death. Importantly, αSyn pathology extends beyond neurons—it also encompasses spreading throughout the neuronal environment and internalization by microglia and astrocytes. Once internalized, glia can act as neuroprotective scavengers, which limit the spread of αSyn. However, they can also become reactive, thereby contributing to neuroinflammation and the progression of PD. Recent advances in αSyn research have enabled the molecular diagnosis of PD and accelerated the development of targeted therapies. Nevertheless, despite more than two decades of research, the cellular function, aggregation mechanisms, and induction of cellular damage by αSyn remain incompletely understood. Unraveling the interplay between αSyn, neurons, and glia may provide insights into disease initiation and progression, which may bring us closer to exploring new effective therapeutic strategies. Herein, we provide an overview of recent studies emphasizing the multifaceted nature of αSyn and its impact on both neuron and glial cell damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Chemistry and Biochemistry, Medical University of Lodz, 92-215 Lodz, Poland.
ORCID-Profile: Kamil Saramowicz, Natalia Siwecka, Grzegorz Galita, Wioletta Rozpędek-Kamińska
Förderung
- Medical University of Lodz
- National Science Center
Zitieren
APA
Saramowicz, K., Siwecka, N., Galita, G., Kucharska-Lusina, A., Rozpędek-Kamińska, W., & Majsterek, I. (2023). Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease. International Journal of Molecular Sciences, 25(1), 360. https://doi.org/10.3390/ijms25010360
Vancouver
Saramowicz K, Siwecka N, Galita G, Kucharska-Lusina A, Rozpędek-Kamińska W, Majsterek I. Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease. International Journal of Molecular Sciences. 2023;25(1):360. doi:10.3390/ijms25010360
BibTeX
@article{Saramowicz2023,
author = {Saramowicz, Kamil and Siwecka, Natalia and Galita, Grzegorz and Kucharska-Lusina, Aleksandra and Rozpędek-Kamińska, Wioletta and Majsterek, Ireneusz},
title = {Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {25},
number = {1},
pages = {360},
doi = {10.3390/ijms25010360}
}
EUVIMED